Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Aug 20;12(1):528.
doi: 10.1186/s13104-019-4569-5.

Febrile neutropenia management in pediatric cancer patients at Ethiopian Tertiary Care Teaching Hospital

Affiliations

Febrile neutropenia management in pediatric cancer patients at Ethiopian Tertiary Care Teaching Hospital

Husnia Bedewi Mohammed et al. BMC Res Notes. .

Abstract

Objective: This study aimed at assessing the management practice of febrile neutropenia (FN) in pediatric cancer patients at Tikur Anbessa Specialized Hospital (TASH), Ethiopia by reviewing patients' charts from 135 participants retrospectively. Data was entered into Epi-info 7 and exported to SPSS 20 for analysis.

Results: Empiric antibiotics therapy (EAT) was given to all patients in which ceftriaxone with gentamycin constituted of 71.8% followed by ceftriaxone monotherapy. EATs were converted to others in 20 (14.8%) and 2 (1.5%) patients for the first and second times respectively, mainly based on poor clinical response without conducting culture and sensitivity tests. These tests were done only for 13 (9.6%) participants and growth was seen in 5 patients; and definitive therapy was given for 2 patients. ANC value was above 500 cell/mm3 in 80.7% of patients and 98.5% of study participants were afebrile after completion FN treatment. Most of them (70.4%) were treated for FN and 7 of patients died due to all case mortality. The hospital should not rely mainly only on ceftriaxone with gentamycin as EAT and should do culture and sensitivity test to optimize therapy based on susceptibility result before conversion and modification of therapy in management of FN.

Keywords: Cancer in pediatrics; Ethiopia; Febrile neutropenia; Tikur Anbessa Specialized Hospital.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

References

    1. Klastersky J, De Naurois J, Rolston K, Rapoport B, Maschmeyer G, Aapro M, et al. Management of febrile neutropaenia: ESMO Clinical Practice Guidelines. Ann Oncol. 2016;27(suppl_5):111–118. doi: 10.1093/annonc/mdw325. - DOI - PubMed
    1. Paul M, Yahav D, Fraser A, Leibovici LJ. Empirical antibiotic monotherapy for febrile neutropenia: systematic review and meta-analysis of randomized controlled trials. J Antimicrob Chemother. 2005;57(2):176–189. doi: 10.1093/jac/dki448. - DOI - PubMed
    1. Lehrnbecher T, Phillips R, Alexander S, Alvaro F, Carlesse F, Fisher B, et al. Guideline for the management of fever and neutropenia in children with cancer and/or undergoing hematopoietic stem-cell transplantation. J Clin Oncol. 2012;30(35):4427–4438. doi: 10.1200/JCO.2012.42.7161. - DOI - PubMed
    1. Rosa RG, Goldani LZJPO. Factors associated with hospital length of stay among cancer patients with febrile neutropenia. PLoS ONE. 2014;9(10):e108969. doi: 10.1371/journal.pone.0108969. - DOI - PMC - PubMed
    1. De Naurois J, Novitzky-Basso I, Gill M, Marti FM, Cullen M, Roila F, et al. Management of febrile neutropenia: ESMO clinical practice guidelines. Ann Oncol. 2010;21(suppl_5):252–256. doi: 10.1093/annonc/mdq196. - DOI - PubMed

Substances

LinkOut - more resources